A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations
Cited by 35
Related Papers
The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
|Signal Transduction and Targeted Therapy|2022|218
Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer
|Oncology Reports|2018|166
Characterization of distinct circular RNA signatures in solid tumors
|Molecular Cancer|2022|84